Skip to Main Content

  • Image not available. Hypersensitivity reactions are responsible for 6% to 10% of adverse reactions to medications. Although some reactions are relatively well defined, the majority are due to mechanisms that are either unknown or poorly understood.
  • Image not available. The following criteria suggest that a drug reaction may be immunologically mediated: (a) the reaction occurs in a small percentage of patients receiving the drug, (b) the observed reaction does not resemble the drug's pharmacologic effect, (c) the type of manifestation is similar to that seen with other allergic reactions (anaphylaxis, urticaria, serum sickness), (d) there is a lag time between first exposure of the drug and reaction, (e) the reaction is reproduced even by minute doses of the drug, (f) the reaction is reproduced by agents with similar chemical structures, (g) eosinophilia is present, or (h) the reaction resolves after the drug has been discontinued. Exceptions to each of these criteria are observed commonly.
  • Image not available. Anaphylaxis is an acute, life-threatening allergic reaction involving multiple organ systems that generally begins within 30 minutes but almost always within 2 hours after exposure to the inciting allergen. Anaphylaxis requires prompt treatment to restore respiratory and cardiovascular function. Epinephrine is administered as primary treatment to counteract bronchoconstriction and vasodilation. Intravenous fluids should be administered to restore intravascular volume.
  • Image not available. Factors that influence the likelihood of allergic drug reactions are the chemical composition of the drug, whether the drug contains proteins of nonhuman origin, the route of drug administration, and the sensitivity of the individual as determined by genetics, or environmental factors. For some drugs, genetic predisposition to specific HLAalleles has been identified as a risk factor for allergic-mediated skin reactions.
  • Image not available. Patients with a history of an immediate reaction to penicillin are advised not to receive cephalosporins if they can be avoided. Patients who have negative penicillin skin tests or experienced only mild cutaneous reactions, such as maculopapular rashes, have a low risk of serious reactions to cephalosporins.
  • Image not available. Less than 1% of patients receiving nonionic radiocontrast agents experience some type of adverse reaction. Of the variety of reactions reported, approximately 90% are allergic like, mostly urticarial, with severe reactions occurring as infrequently as 0.02%.
  • Image not available.Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) can produce two general types of reactions, urticaria/angioedema and rhinosinusitis/asthma, in susceptible patients. About 20% of asthmatics are sensitive to aspirin and other NSAIDs.
  • Image not available. Cross-reactivity between sulfonamide antibiotics and nonantibiotics is low. The low cross-reactive rate may be explained by differences in the chemical structures and reactive metabolites of the sulfonamide antibiotics and nonantibiotics.
  • Image not available. The basic principles of management of allergic reactions to drugs or biologic agents include (a) discontinuation of the medication or agent when possible, (b) treatment of the adverse clinical signs and symptoms, and (c) substitution, if necessary, of another agent.
  • Image not available. One of the most helpful tests to evaluate risk of penicillin allergy is the skin test. Skin testing can demonstrate the presence of penicillin-specific immunoglobulin E and predict a relatively high risk of immediate hypersensitivity reactions. Skin testing does not predict ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.